Triptych

Triptych Therapeutics is an emerging biotechnology company dedicated to the development of next-generation therapeutic pharmaceuticals for autoimmune, inflammatory, and allergic diseases. The company utilizes a proprietary protein engineering platform, likely focused on multi-specific biologics, to design highly targeted treatments for complex immune-mediated conditions. Emerging from stealth around 2024-2025, Triptych Therapeutics is currently in the pre-clinical stage of development, with a strong focus on protein sciences and engineering. The company's approach aims to address unmet medical needs by leveraging advanced molecular architectures to modulate immune responses more effectively than traditional therapies.